Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Headache. 2015 Aug 3;55(10):1358–1364. doi: 10.1111/head.12624

Episodic Syndromes that may be associated with migraine: a.k.a. “the childhood periodic syndromes”

Amy A Gelfand 1,2
PMCID: PMC4715532  NIHMSID: NIHMS698247  PMID: 26234380

Abstract

Previously called “childhood periodic syndromes that are commonly precursors of migraine” in ICHD-II, these disorders were renamed “episodic syndromes that may be associated with migraine” in ICHD-III beta. The specific disorders reviewed in this article include: benign paroxysmal torticollis, benign paroxysmal vertigo, abdominal migraine and cyclical vomiting syndrome, as well as infantile colic which was recently added under the appendix section in ICHD-III beta.

Keywords: pediatric migraine, abdominal migraine, cyclic vomiting syndrome, infant colic, benign paroxysmal torticollis, benign paroxysmal vertigo

Introduction

Recognizing and understanding childhood periodic syndromes is important for several reasons. First, children with these disorders often undergo extensive and sometimes invasive medical testing. Recognizing their disorders as migrainous could spare them such testing. Appropriate treatment for these disorders of course first requires a correct diagnosis. Hearing about a history of a periodic syndrome might help a clinician to diagnose migraine headache in a child or adolescent down the line(1). Lastly, while migraine is clearly a largely genetic disorder, except in the case of the rare subform of familial hemiplegic migraine(2) it has been difficult to tease out the specific genes involved. This may be because the population of all migraineurs is heterogeneous, with different clinical phenotypes. More detailed clinical phenotyping that divides migraineurs into more homogeneous subgroups may facilitate gene discovery—and recognizing and phenotyping migraineurs by presence or absence of these childhood periodic syndromes is one way to improve clinical phenotyping.

In ICHD-II, the migrainous disorders of early childhood were referred to as “Childhood periodic syndromes that are commonly precursors of migraine”(3) or, colloquially, “childhood periodic syndromes”. In the ICHD-III beta version released in 2013, the terminology was changed to “episodic syndromes that may be associated with migraine”(4), partially in recognition that some of these disorders can affect adults. Benign paroxysmal torticollis was moved from the appendix section into the main body of the document, and infant colic was added as a new disorder in the appendix section of ICHD-III beta. Cyclical vomiting syndrome and abdominal migraine were brought under a new umbrella term “recurrent gastrointestinal disturbance”. For brevity, the term “childhood periodic syndromes” will still be used in this review.

This review covers the childhood periodic syndromes in the order of age that they typically occur in childhood: infant colic affects young babies, benign paroxysmal torticollis older infants, benign paroxysmal torticollis typically affects preschool aged children, and abdominal migraine and cyclical vomiting typically school aged children around six or seven years of age. Some children will evolve from one periodic syndrome into another with age(5-7). The latter two disorders have also been reported to have onset in adults, and benign paroxysmal vertigo can occasionally persist into adulthood(5). An important feature for all of these disorders is that between attacks the patients are healthy and have normal neurologic examinations.

Infant Colic

Infant colic, or excessive crying in an otherwise healthy and well-fed infant, occurs in 5-19% of infants(8, 9). Infant crying peaks at 5-6 weeks of life (corrected for gestational age at birth), and declines by 3-4 months of age(10, 11). Colic is an amplified version of this developmental crying pattern. The diagnostic criteria in the ICHD-III beta appendix are adapted from Wessel's criteria for colic, which are often used in pediatrics: crying for at least 3 hours a day, at least 3 days a week, for at least 3 weeks(4, 12). While the term “colic” implies abdominal discomfort as the etiology of the infant's distress, evidence for this localization is limited. Several trials of gastrointestinal oriented therapies have been negative(13-15). In addition, colicky infants typically do the bulk of their crying in the late afternoon and evening hours(10, 11), while feeding in young infants happens around the clock. It is important that we ultimately determine the cause of infant colic, as inconsolable and excessive crying leads to caregiver frustration and is associated with shaken baby syndrome, a form of child abuse with potential for significant neurologic morbidity and mortality(10, 16-18) . One percent of parents of one-month olds admit to having shaken their baby at least once to try to stop crying, and 2.2% have tried either shaking, slapping or smothering. By age six months, 5.6% have tried one of these dangerous techniques(19).

An association between infant colic and migraine has been reported in several retrospective case-control studies(20-22). In a cross-sectional study, mothers with migraine were more than twice as likely to have an infant with colic, pointing to the possible genetic relationship between infant colic and migraine(23). A recent meta-analysis found the odds of migraine were increased if there was a history of infant colic (OR 5.6 (95% CI 3.3-9.5))(24). A recent prospective cohort study done in Finland found that infant colic was associated with increased risk of migraine without aura by age 18 (RR 2.7 (95% CI 1.5-4.7)), but not migraine with aura(25), again highlighting the possibilities that certain genes lead to specific phenotypes of migraine.

Even if infant colic is in fact a migrainous disorder, it is still not known exactly why the babies cry. It may be that they are experiencing headaches, or perhaps abdominal pain analogous to abdominal migraine. It is also possible that these infants have increased sensitivity to stimuli, just a migraineurs do, and that they express that increased sensitivity through excessive crying. With rapid brain development, neonates' visual perceptual ability increases significantly during the first few weeks of life(26). This could explain why colic does not begin until about two weeks of life, even though babies are feeding and interacting from birth onwards. There may also be a role for circadian biology in colic, as there is in migraine. Age three months is when the infant's endogenous melatonin secretion takes on a circadian rhythm that allows for nighttime sleep consolidation(27-29). Rhythmic melatonin secretion, either in itself or mediated by the ability to sleep through the night, could explain why colic resolves around age 3 months(30). Particularly in young children, sleep can help terminate a migraine attack(31).

Additional prospective cohort studies are needed to determine the natural history of children with infant colic—specifically whether they are more likely to go on to develop other childhood periodic syndromes, and whether they are more likely to have earlier onset of migraine headaches or a more severe form of the disorder. Treatment studies of infant colic are needed to see whether principles of managing migraine in children can be used to soothe colicky babies. We know that during a migraine attack children want to climb in bed and pull the covers over their heads and be in a dark, quiet room. A behavioral intervention wherein caregivers are trained to decrease stimulation when colicky crying starts—turn off the lights, quiet the musical toy—could potentially help babies, and in turn help frustrated caregivers, to remain calm. There is in fact a small study suggesting that such a strategy may be effective(32). Given how much additional evidence has accumulated about the relationship between infant colic and migraine since the ICHD-III beta version was released, it would seem sensible to bring it into the main document of the final 3rd edition(33).

Benign Paroxysmal Torticollis of infancy

The hallmark of this disorder is periodic, stereotyped bouts of torticollis during infancy(4). Onset is typically around five or six months of age(34). Attack duration can be on the order of minutes but typically last hours to days, and usually occur at regular intervals (e.g. monthly)(4, 35). The disorder typically begins to improve by age two and typically resolves by age three or four(34). There may be associated irritability, drowsiness, pallor, vomiting, ataxia, or tortipelvis(34, 35). Motor delay has been reported in some cases, and may improve as the disorder improves(34, 35). Often there is a family history of migraine. In some cases the infants have one of the CACNA1A gene mutations that have been associated with familial hemiplegic migraine(7, 36, 37). The disorder may be underdiagnosed as one study found that only 2.4% of pediatricians were aware of benign paroxysmal torticollis, however it also seems to be the rarest of the periodic syndromes(35, 38). Diagnostic yield of brain MRI and EEG are quite low(34). Treatment of benign paroxysmal torticollis is not well studied.

Benign Paroxysmal Vertigo of Childhood

Children with this disorder experience recurrent attacks of vertigo that seem to come out of the blue and last seconds to hours(4, 5), with the most common duration being less than five minutes(39). There can be accompanying nystagmus, ataxia, nausea/vomiting or pallor, and the child may appear scared(4, 39). Headache can also accompany an attack(5, 6, 39). To formally meet ICHD-III beta criteria there needs to be normal audiometric and vestibular functions between attacks, but the requirement for a normal EEG found in ICHD-II(3) has been removed. However in cases where it is not clear that alteration of mental status is absent, obtaining an EEG is probably still worthwhile. As young children may have difficulty articulating vertigo, a parent's observation of episodic periods of unsteadiness is sufficient to infer vertigo in young children(4). This is analogous to how sensitivity to light and sound can be inferred from behavior in young children with migraine headache.

Typical age of onset is between two and five years of age(5, 39, 40). Some patients outgrow the disorder, typically around age 5-6 years(5, 40), however for others attacks can persist into adolescence or young adulthood(5). In one series that had long-term follow-up, a family history of migraine was seen in 70% and a third went on to have migraine as adults, which was higher than would be expected in the general population(40). In another small series with long term follow-up 69% had migraine(5). Timing of migraine onset is not well studied, but in one series 20% of children with BPV had developed migrainous headaches by age 7.5 years (median), which is higher than the population prevalence for age(39). Those cases that went on to develop migraine as adults had experienced benign paroxysmal vertigo in childhood for longer than those that did not (mean 3.01 years vs. 1.9 years, p=0.01)(40). It is possible that a genetic distinction differentiates those who have an age-sensitive time-limited disorder from those with a more chronic course. A mutation in the CACNA1A gene has been reported in a patient who first had benign paroxysmal torticollis, then benign paroxysmal vertigo, then hemiplegic migraine(7).

Cyclic Vomiting Syndrome

Children with cyclic vomiting syndrome (CVS) experience stereotyped episodes of frequent vomiting. The episodes are typically stereotyped for a particular individual and often occur at predictable intervals(4). By ICHD-III beta criteria, the vomiting must be at least four times per hour, though in ICHD-II it was required to be at least four times per hour for at least one hour during the episode, which seems to be a more reasonable criterion(3, 4). Children with cyclic vomiting syndrome are well between attacks.

CVS has also been reported to occur in adults. In children, mean age at onset is 5.2 years, whereas for adults it is 25.4 years. Attack frequency is about once a month on average and attack duration is typically several days. A personal or family history of migraine headache is common(41).

The differential diagnosis for cyclic vomiting syndrome is broad. Gastrointestinal pathology should be ruled out via consultation with a GI specialist and appropriate testing. Urologic disorders, such as ureteropelvic junction obstruction causing hydronephrosis, have been reported and can be diagnosed via abdominal ultrasound(42).

For the pediatric neurologist, a specialty-based differential to consider would include:

  1. Autonomic seizures—In pre-adolescent children, Panyiotopoulous syndrome (peak age at onset 3-6 years) and Gastaut type epilepsy (peak age at onset 8-11 years) would be diagnostic considerations(43), particularly if there is alteration of mental status.

  2. Cannabinoid hyperemesis syndrome—This recently recognized disorder should be on the differential for an adolescent with cyclic vomiting. Frequent use of cannabis can lead to a periodic vomiting syndrome accompanied by a predilection for hot-water bathing(44).

  3. Metabolic disorders—Serum and/or urine laboratory testing suggesting mitochondrial dysfunction has been reported in some children with CVS(45, 46). The mitochondrial DNA polymorphisms 16519C→T and 3010G→A have been associated with CVS in children(47). Rarely cyclic vomiting can be a presentation of disorders of fatty acid oxidation(48, 49).

Acute treatment consists of oral hydration or intravenous hydration if needed, as well as anti-emetics. Case series have suggested triptans are effective acute therapy in some patients. Given the significant vomiting, typically nasal spray or subcutaneous sumatriptan are used(50-53) however successful treatment with oral sumatriptan has also been reported(54). As the episodes are often quite debilitating, treatment with a migraine preventive may be worthwhile, though there are no randomized trials to guide agent selection. The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition recommend amitriptyline for children age 5 and up and cyproheptadine for younger children(55). There is some evidence that amitriptyline may be superior to propranolol for CVS prevention in children(56). The neurokinin-1 receptor antagonist aprepitant was found to be effective both as an acute therapy and as a preventive therapy (dosed twice weekly) for CVS in an open-label study(57).

Abdominal Migraine

This disorder usually has its onset in school-aged children and is characterized by bouts of abdominal pain lasting 2-72 hours in duration. Typically the pain is dull and often in the midline or poorly localized. The child may experience nausea, vomiting, anorexia, or pallor during the attacks(4). The children are well between attacks. Similarly to in cyclic vomiting syndrome, no gastrointestinal pathology is identifiable.

Abdominal migraine is likely the most common childhood periodic syndrome to present in a pediatric headache clinic; in one series accounting for 48.9%(38). The population prevalence has been estimated at 4.1% among 5-15 year olds(58). Mean age of onset is 7 years (SD 3.2). The mean attack frequency is 14 episodes per year, but with high variance (SD 22.4). Mean attack duration is 17 hours (SD 18.1), with a range of 1-72 hours(58).

There are case reports of successful treatment of acute attacks with nasal spray sumatriptan(59). As with cyclic vomiting syndrome, treatment with a migraine preventive may be worth consideration. A small case series suggests a course of IV dihydroergotamine may be helpful for refractory abdominal migraine in children(60). Randomized controlled trials of acute treatments for abdominal migraine are needed. If triptans are shown to be effective for acute treatment of abdominal migraine, it would be helpful to establish the positive predictive value of successful termination of an attack with a triptan in a child presenting with recurrent migrainous abdominal pain. If the positive predictive value is high, perhaps children could be spared invasive testing such as upper endoscopy and colonoscopy.

Conclusions

The “episodic syndromes that may be associated with migraine” are a diverse group of disorders that predominantly occur in children but in some cases can also occur in adults. Recognition of these disorders is important for accurate diagnosis and treatment. Given the typically early childhood age of onset, the migrainous genetic underpinnings of these disorders would be expected to be strong. Detailed clinical phenotyping of children with these disorders could help in the search for specific migraine genes. There are not yet randomized clinical trials to guide treatment for these disorders. In some cases behavioral treatment, such as decreasing stimulation around a colicky infant, may be all that is needed and might be most appropriate in the youngest age group. In older children with frequent or disabling attacks, migraine preventives and acute treatments may be necessary and appropriate.

Acknowledgments

Conflicts of Interest: Dr. Gelfand receives grant support from NIH/NCATS (8KL2TR000143-09), UCSF CTSI, Allergan and the Migraine Research Foundation. She has received honoraria from Journal Watch Neurology and has consulted for FCB, a medical consulting organization. She has received personal compensation for medical-legal consulting.

Funding source: There was no specific funding for this manuscript, though Dr. Gelfand was receiving salary support from NIH/NCATS (8KL2TR000143-09) while writing it.

Abbreviations

CVS

cyclic vomiting syndrome

BPT

benign paroxysmal torticollis

BPV

benign paroxysmal vertigo

References

  • 1.Ozge A, Aydinlar E, Tasdelen B. Grey zones in the diagnosis of adult migraine without aura based on the International Classification of Headache Disorders-III beta: Exploring the covariates of possible migraine without aura. Pain research & management : the journal of the Canadian Pain Society = journal de la societe canadienne pour le traitement de la douleur. 2015;20:e1–7. doi: 10.1155/2015/234193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet neurology. 2011;10:457–70. doi: 10.1016/S1474-4422(11)70048-5. [DOI] [PubMed] [Google Scholar]
  • 3.Headache Classification Subcommittee of the International Headache S. The International Classification of Headache Disorders: 2nd edition. Cephalalgia : an international journal of headache. 2004;24(Suppl 1):9–160. doi: 10.1111/j.1468-2982.2003.00824.x. [DOI] [PubMed] [Google Scholar]
  • 4.The International Classificatio of Headache Disorders, 3rd edition (beta version) Cephalalgia : an international journal of headache. 2013;33:629–808. doi: 10.1177/0333102413485658. [DOI] [PubMed] [Google Scholar]
  • 5.Krams B, Echenne B, Leydet J, Rivier F, Roubertie A. Benign paroxysmal vertigo of childhood: long-term outcome. Cephalalgia : an international journal of headache. 2011;31:439–43. doi: 10.1177/0333102410382797. [DOI] [PubMed] [Google Scholar]
  • 6.Langhagen T, Lehrer N, Borggraefe I, Heinen F, Jahn K. Vestibular migraine in children and adolescents: clinical findings and laboratory tests. Frontiers in neurology. 2014;5:292. doi: 10.3389/fneur.2014.00292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cuenca-Leon E, Corominas R, Fernandez-Castillo N, Volpini V, Del Toro M, Roig M, et al. Genetic analysis of 27 Spanish patients with hemiplegic migraine, basilar-type migraine and childhood periodic syndromes. Cephalalgia : an international journal of headache. 2008;28:1039–47. doi: 10.1111/j.1468-2982.2008.01645.x. [DOI] [PubMed] [Google Scholar]
  • 8.Castro-Rodriguez JA, Stern DA, Halonen M, Wright AL, Holberg CJ, Taussig LM, Martinez FD. Relation between infantile colic and asthma/atopy: a prospective study in an unselected population. Pediatrics. 2001;108:878–82. doi: 10.1542/peds.108.4.878. [DOI] [PubMed] [Google Scholar]
  • 9.Lucassen PL, Assendelft WJ, van Eijk JT, Gubbels JW, Douwes AC, van Geldrop WJ. Systematic review of the occurrence of infantile colic in the community. Archives of disease in childhood. 2001;84:398–403. doi: 10.1136/adc.84.5.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Barr RG, Trent RB, Cross J. Age-related incidence curve of hospitalized Shaken Baby Syndrome cases: convergent evidence for crying as a trigger to shaking. Child abuse & neglect. 2006;30:7–16. doi: 10.1016/j.chiabu.2005.06.009. [DOI] [PubMed] [Google Scholar]
  • 11.Brazelton TB. Crying in infancy. Pediatrics. 1962;29:579–88. [PubMed] [Google Scholar]
  • 12.Wessel MA, Cobb JC, Jackson EB, Harris GS, Jr, Detwiler AC. Paroxysmal fussing in infancy, sometimes called colic. Pediatrics. 1954;14:421–35. [PubMed] [Google Scholar]
  • 13.Metcalf TJ, Irons TG, Sher LD, Young PC. Simethicone in the treatment of infant colic: a randomized, placebo-controlled, multicenter trial. Pediatrics. 1994;94:29–34. [PubMed] [Google Scholar]
  • 14.Sung V, Hiscock H, Tang ML, Mensah FK, Nation ML, Satzke C, et al. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. Bmj. 2014;348:g2107. doi: 10.1136/bmj.g2107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics. 2008;122:8–12. doi: 10.1542/peds.2007-1192. [DOI] [PubMed] [Google Scholar]
  • 16.Fujiwara T, Barr RG, Brant R, Barr M. Infant distress at five weeks of age and caregiver frustration. The Journal of pediatrics. 2011;159:425–30 e1. 2. doi: 10.1016/j.jpeds.2011.02.010. [DOI] [PubMed] [Google Scholar]
  • 17.Lee C, Barr RG, Catherine N, Wicks A. Age-related incidence of publicly reported shaken baby syndrome cases: is crying a trigger for shaking? Journal of developmental and behavioral pediatrics : JDBP. 2007;28:288–93. doi: 10.1097/DBP.0b013e3180327b55. [DOI] [PubMed] [Google Scholar]
  • 18.Talvik I, Alexander RC, Talvik T. Shaken baby syndrome and a baby's cry. Acta paediatrica. 2008;97:782–5. doi: 10.1111/j.1651-2227.2008.00778.x. [DOI] [PubMed] [Google Scholar]
  • 19.Reijneveld SA, van der Wal MF, Brugman E, Sing RA, Verloove-Vanhorick SP. Infant crying and abuse. Lancet. 2004;364:1340–2. doi: 10.1016/S0140-6736(04)17191-2. [DOI] [PubMed] [Google Scholar]
  • 20.Jan MM, Al-Buhairi AR. Is infantile colic a migraine-related phenomenon? Clinical pediatrics. 2001;40:295–7. doi: 10.1177/000992280104000512. [DOI] [PubMed] [Google Scholar]
  • 21.Bruni O, Fabrizi P, Ottaviano S, Cortesi F, Giannotti F, Guidetti V. Prevalence of sleep disorders in childhood and adolescence with headache: a case-control study. Cephalalgia : an international journal of headache. 1997;17:492–8. doi: 10.1046/j.1468-2982.1997.1704492.x. [DOI] [PubMed] [Google Scholar]
  • 22.Romanello S, Spiri D, Marcuzzi E, Zanin A, Boizeau P, Riviere S, et al. Association between childhood migraine and history of infantile colic. JAMA : the journal of the American Medical Association. 2013;309:1607–12. doi: 10.1001/jama.2013.747. [DOI] [PubMed] [Google Scholar]
  • 23.Gelfand AA, Thomas KC, Goadsby PJ. Before the headache: infant colic as an early life expression of migraine. Neurology. 2012;79:1392–6. doi: 10.1212/WNL.0b013e31826c1b7b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gelfand AA, Goadsby PJ, Allen IE. The relationship between migraine and infant colic: a systematic review and meta-analysis. Cephalalgia : an international journal of headache. 2015;35:63–72. doi: 10.1177/0333102414534326. [DOI] [PubMed] [Google Scholar]
  • 25.Sillanpaa M, Saarinen M. Infantile colic associated with childhood migraine: A prospective cohort study. Cephalalgia : an international journal of headache. 2015 doi: 10.1177/0333102415576225. [DOI] [PubMed] [Google Scholar]
  • 26.Moller H. Milestones and normative data. In: Taylor D, Hoyt C, editors. Pediatric Ophthalmology and Strabismus. 3rd ed. Edinburgh: Elsevier; 2005. p. 40. [Google Scholar]
  • 27.Kennaway DJ, Goble FC, Stamp GE. Factors influencing the development of melatonin rhythmicity in humans. The Journal of clinical endocrinology and metabolism. 1996;81:1525–32. doi: 10.1210/jcem.81.4.8636362. [DOI] [PubMed] [Google Scholar]
  • 28.Henderson JM, France KG, Owens JL, Blampied NM. Sleeping through the night: the consolidation of self-regulated sleep across the first year of life. Pediatrics. 2010;126:e1081–7. doi: 10.1542/peds.2010-0976. [DOI] [PubMed] [Google Scholar]
  • 29.Henderson JM, France KG, Blampied NM. The consolidation of infants' nocturnal sleep across the first year of life. Sleep medicine reviews. 2011;15:211–20. doi: 10.1016/j.smrv.2010.08.003. [DOI] [PubMed] [Google Scholar]
  • 30.Epstein LG, Zee PC. Infantile colic and migraine. JAMA : the journal of the American Medical Association. 2013;309:1636–7. doi: 10.1001/jama.2013.3873. [DOI] [PubMed] [Google Scholar]
  • 31.Aaltonen K, Hamalainen ML, Hoppu K. Migraine attacks and sleep in children. Cephalalgia : an international journal of headache. 2000;20:580–4. doi: 10.1046/j.1468-2982.2000.00089.x. [DOI] [PubMed] [Google Scholar]
  • 32.McKenzie S. Troublesome crying in infants: effect of advice to reduce stimulation. Archives of disease in childhood. 1991;66:1416–20. doi: 10.1136/adc.66.12.1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Gelfand AA. Infant colic-a baby's migraine? Cephalalgia : an international journal of headache. 2015 doi: 10.1177/0333102415576224. [DOI] [PubMed] [Google Scholar]
  • 34.Rosman NP, Douglass LM, Sharif UM, Paolini J. The neurology of benign paroxysmal torticollis of infancy: report of 10 new cases and review of the literature. Journal of child neurology. 2009;24:155–60. doi: 10.1177/0883073808322338. [DOI] [PubMed] [Google Scholar]
  • 35.Hadjipanayis A, Efstathiou E, Neubauer D. Benign paroxysmal torticollis of infancy: An underdiagnosed condition. Journal of paediatrics and child health. 2015 doi: 10.1111/jpc.12841. [DOI] [PubMed] [Google Scholar]
  • 36.Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Developmental medicine and child neurology. 2002;44:490–3. doi: 10.1017/s0012162201002407. [DOI] [PubMed] [Google Scholar]
  • 37.Vila-Pueyo M, Gene GG, Flotats-Bastardes M, Elorza X, Sintas C, Valverde MA, et al. A loss-of-function CACNA1A mutation causing benign paroxysmal torticollis of infancy. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. 2014;18:430–3. doi: 10.1016/j.ejpn.2013.12.011. [DOI] [PubMed] [Google Scholar]
  • 38.Tarantino S, Capuano A, Torriero R, Citti M, Vollono C, Gentile S, et al. Migraine equivalents as part of migraine syndrome in childhood. Pediatric neurology. 2014;51:645–9. doi: 10.1016/j.pediatrneurol.2014.07.018. [DOI] [PubMed] [Google Scholar]
  • 39.Batu ED, Anlar B, Topcu M, Turanli G, Aysun S. Vertigo in childhood: A retrospective series of 100 children. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. 2015;19:226–32. doi: 10.1016/j.ejpn.2014.12.009. [DOI] [PubMed] [Google Scholar]
  • 40.Batuecas-Caletrio A, Martin-Sanchez V, Cordero-Civantos C, Guardado-Sanchez L, Marcos MR, Fabian AH, et al. Is benign paroxysmal vertigo of childhood a migraine precursor? European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. 2013;17:397–400. doi: 10.1016/j.ejpn.2013.01.006. [DOI] [PubMed] [Google Scholar]
  • 41.Lee LY, Abbott L, Mahlangu B, Moodie SJ, Anderson S. The management of cyclic vomiting syndrome: a systematic review. European journal of gastroenterology & hepatology. 2012;24:1001–6. doi: 10.1097/MEG.0b013e328355638f. [DOI] [PubMed] [Google Scholar]
  • 42.Paul Rosman N, Dutt M, Nguyen HT. A curable and probably often-overlooked cause of cyclic vomiting syndrome. Seminars in pediatric neurology. 2014;21:60–5. doi: 10.1016/j.spen.2014.04.001. [DOI] [PubMed] [Google Scholar]
  • 43.Michael M, Tsatsou K, Ferrie CD. Panayiotopoulos syndrome: an important childhood autonomic epilepsy to be differentiated from occipital epilepsy and acute non-epileptic disorders. Brain & development. 2010;32:4–9. doi: 10.1016/j.braindev.2009.03.002. [DOI] [PubMed] [Google Scholar]
  • 44.Simonetto DA, Oxentenko AS, Herman ML, Szostek JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clinic proceedings. 2012;87:114–9. doi: 10.1016/j.mayocp.2011.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Moses J, Keilman A, Worley S, Radhakrishnan K, Rothner AD, Parikh S. Approach to the diagnosis and treatment of cyclic vomiting syndrome: a large single-center experience with 106 patients. Pediatric neurology. 2014;50:569–73. doi: 10.1016/j.pediatrneurol.2014.02.009. [DOI] [PubMed] [Google Scholar]
  • 46.Boles RG, Williams JC. Mitochondrial disease and cyclic vomiting syndrome. Digestive diseases and sciences. 1999;44:103S–7S. [PubMed] [Google Scholar]
  • 47.Yorns WR, Jr, Hardison HH. Mitochondrial dysfunction in migraine. Seminars in pediatric neurology. 2013;20:188–93. doi: 10.1016/j.spen.2013.09.002. [DOI] [PubMed] [Google Scholar]
  • 48.Fitzgerald M, Crushell E, Hickey C. Cyclic vomiting syndrome masking a fatal metabolic disease. European journal of pediatrics. 2013;172:707–10. doi: 10.1007/s00431-012-1852-z. [DOI] [PubMed] [Google Scholar]
  • 49.Rinaldo P. Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome. Digestive diseases and sciences. 1999;44:97S–102S. [PubMed] [Google Scholar]
  • 50.Calhoun AH, Pruitt AP. Injectable sumatriptan for cyclic vomiting syndrome in adults: a case series. Headache. 2014;54:1526–30. doi: 10.1111/head.12444. [DOI] [PubMed] [Google Scholar]
  • 51.Hikita T, Kodama H, Kaneko S, Amakata K, Ogita K, Mochizuki D, et al. Sumatriptan as a treatment for cyclic vomiting syndrome: a clinical trial. Cephalalgia : an international journal of headache. 2011;31:504–7. doi: 10.1177/0333102410390398. [DOI] [PubMed] [Google Scholar]
  • 52.Kowalczyk M, Parkman H, Ward L. Adult cyclic vomiting syndrome successfully treated with intranasal sumatriptan. Journal of general internal medicine. 2010;25:88–91. doi: 10.1007/s11606-009-1162-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kakisaka Y, Wakusawa K, Sato I, Haginoya K, Uematsu M, Hirose M, et al. Successful treatment with sumatriptan in a case with cyclic vomiting syndrome combined with 18q- syndrome. Journal of child neurology. 2009;24:1561–3. doi: 10.1177/0883073809334384. [DOI] [PubMed] [Google Scholar]
  • 54.Okumura T, Ohhira M, Kumei S, Nozu T. An adult patient with cyclic vomiting syndrome successfully treated with oral sumatriptan. The American journal of gastroenterology. 2014;109:292–3. doi: 10.1038/ajg.2013.372. [DOI] [PubMed] [Google Scholar]
  • 55.Li BU, Lefevre F, Chelimsky GG, Boles RG, Nelson SP, Lewis DW, et al. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. Journal of pediatric gastroenterology and nutrition. 2008;47:379–93. doi: 10.1097/MPG.0b013e318173ed39. [DOI] [PubMed] [Google Scholar]
  • 56.Treepongkaruna S, Jarasvaraparn C, Tanpowpong P, Lertudomphonwanit C. Short- and long-term outcomes of children with cyclic vomiting syndrome. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2014;97:1077–83. [PubMed] [Google Scholar]
  • 57.Cristofori F, Thapar N, Saliakellis E, Kumaraguru N, Elawad M, Kiparissi F, et al. Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome. Alimentary pharmacology & therapeutics. 2014;40:309–17. doi: 10.1111/apt.12822. [DOI] [PubMed] [Google Scholar]
  • 58.Abu-Arafeh I, Russell G. Prevalence and clinical features of abdominal migraine compared with those of migraine headache. Archives of disease in childhood. 1995;72:413–7. doi: 10.1136/adc.72.5.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Kakisaka Y, Wakusawa K, Haginoya K, Saito A, Uematsu M, Yokoyama H, et al. Efficacy of sumatriptan in two pediatric cases with abdominal pain-related functional gastrointestinal disorders: does the mechanism overlap that of migraine? Journal of child neurology. 2010;25:234–7. doi: 10.1177/0883073809336875. [DOI] [PubMed] [Google Scholar]
  • 60.Raina M, Chelimsky G, Chelimsky T. Intravenous dihydroergotamine therapy for pediatric abdominal migraines. Clinical pediatrics. 2013;52:918–21. doi: 10.1177/0009922813492879. [DOI] [PubMed] [Google Scholar]

RESOURCES